Suloctidil, a new vasodilator agent which also stimulates brain energy metabolism, was administered to 26 patients with cerebral vascular disorders. The treatment period, with capsules containing mg 200 of suloctidil, was always 14 days. The therapy induced a good reduction of clinical and psychic symptoms, of high blood pressure values and of some laboratory tests (Breddin test, blood cholesterol).
|Translated title of the contribution||'Clinical trial with a new substance active in the treatment of patients with vascular brain disorders'|
|Number of pages||5|
|Journal||Giornale di Gerontologia|
|Publication status||Published - 1980|
ASJC Scopus subject areas
- Geriatrics and Gerontology